Inflammatory biomarkers to predict outcomes in kidney cancer
There still remains the need for a reliable biomarker to [...]
Surgical treatment of inferior vena cava tumour thrombi in kidney cancer
The formation of a cancerous blood clot, or thrombus, in [...]
Potential biomarker for response to nivolumab for kidney cancer
Nivolumab was the first immunotherapy to be approved for the [...]
Potential screening blood test for early kidney cancer
Researchers at the Dana-Farber Cancer Institute in Boston, USA have [...]
New targeted therapy shows potential for previously treated metastatic kidney cancer
A phase II study published in Frontiers in Oncology last [...]
Ipilimumub plus nivolumab combination after prior treatment with immune checkpoint inhibitors
This retrospective study published in the Journal of Clinical Oncology [...]
Genetic profiling of renal medullary carcinoma paves the way for a potential treatment
Renal medullary carcinoma (RMC) is an aggressive cancer that mainly [...]
ASCO 2020: Implications of the research presented at ASCO 2020 on the treatment of advanced kidney cancer
In this video presentation, Dr Toni Chouieri discusses the SAVOIR, [...]
The effect of age and gender on outcomes in kidney cancer
In this interview, Dr Rana McKay discusses the impact of [...]
Sunitinib re-challenge in patients with metastatic kidney cancer
A study published in Clinical Genitourinary Cancer looks at the [...]
